Securing America's Public Health & National Defense.

AGI plays a critical role in sustaining the nation’s preparedness against biological threats. In today’s world, where pandemics, engineered pathogens, and bioweapons are no longer distant possibilities but real risks, the United States cannot afford to depend on overseas supply chains. A reliable, domestic supply of purpose-bred nonhuman primates is essential to national security, vaccine readiness, and countermeasure development.

We see this responsibility as a matter of patriotic duty. Our campuses serve as a strategic reserve of animals, expertise, and infrastructure, ensuring continuity of operations even during crisis conditions. Facilities are built with robust biosecurity, ensuring that critical research will proceed without disruption. This capacity enables government programs to act quickly, with confidence that resources and infrastructure will be available when needed most.

AGI has long-standing partnerships with U.S. government agencies, supporting vaccine development, biodefense priorities, and high-consequence biomedical research. Our work ensures that taxpayer resources are used responsibly, delivering reproducible outcomes that align with regulatory and scientific standards. By maintaining sovereign primate research capacity, AGI strengthens national resilience and helps ensure that the United States sets the pace in biomedical innovation and defense.

Our role is to provide the dependable foundation on which federal programs can build. At AGI, we are committed to serving the national interest by delivering the secure infrastructure, scientific expertise, and operational continuity that protect public health and support America’s long-term national interests.